Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Kura Oncology (KURA) Operating Income: 2010-2024

Historic Operating Income for Kura Oncology (KURA) over the last 7 years, with Dec 2024 value amounting to -$193.2 million.

  • Kura Oncology's Operating Income fell 33.59% to -$80.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$239.8 million, marking a year-over-year change of. This contributed to the annual value of -$193.2 million for FY2024, which is 16.52% down from last year.
  • As of FY2024, Kura Oncology's Operating Income stood at -$193.2 million, which was down 16.52% from -$165.8 million recorded in FY2023.
  • In the past 5 years, Kura Oncology's Operating Income ranged from a high of -$139.9 million in FY2022 and a low of -$193.2 million during FY2024.
  • Its 3-year average for Operating Income is -$166.3 million, with a median of -$165.8 million in 2023.
  • Data for Kura Oncology's Operating Income shows a maximum YoY decreased of 18.55% (in 2023) over the last 5 years.
  • Kura Oncology's Operating Income (Yearly) stood at -$139.9 million in 2022, then decreased by 18.55% to -$165.8 million in 2023, then declined by 16.52% to -$193.2 million in 2024.